"The Smilow Cancer Hospital Care Center on the Greenwich Hospital campus provides access to expert cancer care and treatment to patients from lower Fairfield County, Connecticut, and Westchester County, New York. Comprehensive outpatient cancer services, including consultation, screening, diagnosis, treatment and follow-up care are located in the Bendheim building. Surgery, if necessary, is performed in the main hospital. Cancer patients who are admitted to Greenwich Hospital are cared for by specially trained staff on a dedicated oncology unit."

During the past decade, Bendheim Cancer Center at Greenwich Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bendheim Cancer Center at Greenwich Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Aptuit" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Bendheim Cancer Center at Greenwich Hospital" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Lung Cancer" (1 trials), "Neurotoxicity" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "Bendheim Cancer Center at Greenwich Hospital" in a lesser frequency.

Most popular intervention types in "Bendheim Cancer Center at Greenwich Hospital" are "Drug" (4 trials), "Other" (3 trials), "Biological" (2 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (3 trials), "cetuximab" (2 trials), "FOLFIRI" (1 trials), "FOLFOX or" (1 trials) and "bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bendheim Cancer Center at Greenwich Hospital" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Bendheim Cancer Center at Greenwich Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Bendheim Cancer Center at Greenwich Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bendheim Cancer Center at Greenwich Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".